Collaborative Targeted Case Management in Improving Functional Status in Patients with Stage III-IV Cancer

Overview

About this study

This randomized clinical trial studies collaborative targeted case management in improving functional status in patients with stage III-IV cancer. Collaborative targeted case management may improve functional status and preserve performance in patients with advanced cancer

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Diagnosis of stage III or stage IV cancer
  • Life expectancy > 6 months
  • Ambulatory Post Acute Care (APC) score between 53 and 66
  • Ability to complete questionnaire(s) by themselves or with assistance
  • Provide informed written consent
  • Have working phone to communicate with study team
  • Fluent in English
  • Sufficient auditory acuity
  • Intact cognitive status

Exclusion Criteria:

  • Patient is within 2 months of a major surgical procedure

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Andrea Cheville, M.D.

Closed for enrollment

Contact information:

Cancer Center Clinical Trials Referral Office

855-776-0015

More information

Publications

Publications are currently not available

Study Results Summary

Not yet available

Supplemental Study Information

Not yet available

.
CLS-20115496

Mayo Clinic Footer